All patients were ... Study Finds Regular Aspirin Use Associated With Greatest Reduction in Colorectal Cancer Among Those Most at Risk Aug. 1, 2024 — In a study of more than 100,000 people ...

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting ...

“Up to 30% of women have them and don't know,” Samy Iskandar, an obstetrician and gynecologist at Bon Secours OB-GYN, said.

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Good day and welcome to the FibroGen third-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to hand the call over to David ...

Topline results from Phase 2 portion of the investigator-sponsored study of FG-3246, a first-in-class antibody-drug conjugate (ADC) targeting ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

This important paper uses elegant models, including genetic knock outs, to demonstrate that FABP4 contributes to lipid accumulation in tumor-associated macrophages, which seems to increase breast ...

James Van Der Beek officially announced in an interview with People that he has been diagnosed with colorectal cancer at 47 ...